BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12132559)

  • 1. Esomeprazole: a clinical review.
    Johnson TJ; Hedge DD
    Am J Health Syst Pharm; 2002 Jul; 59(14):1333-9. PubMed ID: 12132559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esomeprazole: a review of its use in the management of acid-related disorders.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of esomeprazole in the treatment of acid disorders.
    Johnson DA
    Expert Opin Pharmacother; 2003 Feb; 4(2):253-64. PubMed ID: 12562316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of esomeprazole in patients with acid-peptic disorders.
    Beck J
    Gastroenterol Nurs; 2004; 27(2):44-9. PubMed ID: 15082946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esomeprazole for acid peptic disorders.
    Kale-Pradhan PB; Landry HK; Sypula WT
    Ann Pharmacother; 2002 Apr; 36(4):655-63. PubMed ID: 11918517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole magnesium (Nexium).
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
    J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharma clinics medication of the month. Esomeprazole].
    Louis E
    Rev Med Liege; 2002 Sep; 57(9):610-2. PubMed ID: 12440351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
    Raghunath AS; Green JR; Edwards SJ
    Clin Ther; 2003 Jul; 25(7):2088-101. PubMed ID: 12946553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esomeprazole.
    Spencer CM; Faulds D
    Drugs; 2000 Aug; 60(2):321-9; discussion 330-1. PubMed ID: 10983736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of esomeprazole and its role in gastric acid related diseases.
    Saccar CL
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1113-24. PubMed ID: 19606942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esomeprazole: update and clinical review.
    Baker DE
    Rev Gastroenterol Disord; 2002; 2(4):189-99. PubMed ID: 12481170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy.
    Thitiphuree S; Talley NJ
    Int J Clin Pract; 2000 Oct; 54(8):537-41. PubMed ID: 11198734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Sharma P; Johnson DA; Monyak JT; Illueca M
    Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
    Edwards SJ; Lind T; Lundell L
    Aliment Pharmacol Ther; 2006 Sep; 24(5):743-50. PubMed ID: 16918878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.